Getting cytisine licensed for use world-wide: a call to action-Reference-Cited by-同舟云学术

Getting cytisine licensed for use world-wide: a call to action

Published:2016-07-17 Issue:11 Volume:111 Page:1895-1898
ISSN:0965-2140
Container-title:Addiction
language:en
Short-container-title:Addiction

Author:

Walker Natalie¹,Bullen Chris²,Barnes Joanne³,McRobbie Hayden⁴,Tutka Piotr⁵,Raw Martin⁶,Etter Jean-François⁷,Siddiqi Kamran⁸,Courtney Ryan J.⁹,Castaldelli-Maia João Mauricio¹⁰,Selby Peter¹¹^ORCID,Sheridan Janie¹²,Rigotti Nancy A.¹³

Affiliation:

1. National Institute for Health Innovation and Centre for Addiction Research, School of Population Health; University of Auckland; Auckland New Zealand

2. National Institute for Health Innovation, School of Population Health; University of Auckland; Auckland New Zealand

3. School of Pharmacy; University of Auckland; Auckland New Zealand

4. Queen Mary University of London; London UK

5. Department of Pharmacology, Centre for Innovative Research for Medical and Natural Sciences; University of Rzeszów; Rzeszów Poland

6. UK Centre for Tobacco Control Studies; University of Nottingham; Nottingham UK

7. Faculty of Medicine; University of Geneva; Geneva Switzerland

8. Department of Health Sciences; University of York; York UK

9. National Drug and Alcohol, Research Centre; University of New South Wales; Sydney Australia

10. Department of Neuroscience; Medical School, Fundação do ABC; Santo André Brazil

11. Departments of Family and Community Medicine, Psychiatry and Public Health Sciences; University of Toronto; Toronto Canada

12. School of Pharmacy and Centre for Addiction Research; University of Auckland; Auckland New Zealand

13. Harvard Medical School, Tobacco Research and Treatment Center; Massachusetts General Hospital; Boston USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Medicine (miscellaneous)

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/add.13464/fullpdf

Reference19 articles.

1. A survey of tobacco dependence treatment services in 121 countries;Piné-Abata;Addiction,2013

2. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation;Coe;J Med Chem,2005

3. Cytisine for the treatment of nicotine addiction: from a molecule to therapeutic efficacy;Tutka;Pharmacol Rep,2006

4. Cytisine, the world's oldest smoking cessation aid;Prochaska;BMJ,2013

5. Pharmacokinetics of cytisine, an α4β2 nicotinic receptor partial agonist, in healthy smokers following a single dose;Jeong;Drug Test Anal,2014

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cytisine: State of the art in pharmacological activities and pharmacokinetics;Biomedicine & Pharmacotherapy;2024-02

2. Cytisine for smoking cessation: A systematic review and meta-analysis;Drug and Alcohol Dependence;2023-10

3. Electronic nicotine delivery systems (ENDS): A convenient means of smoking?;Pharmacological Research;2023-09

4. Heat capacity of cytisine – the drug for smoking cessation;European Journal of Pharmaceutical Sciences;2023-04

5. Cytisine Therapy Improved Smoking Cessation in the Randomized Screening and Multiple Intervention on Lung Epidemics Lung Cancer Screening Trial;Journal of Thoracic Oncology;2022-11